Purification engineering technology research center of Sichuan Province Natural Medicine
四川省天然药物分离纯化工程技术研究中心

文献

Liu J, Li J, Zhang W, Dong Y, Wang F, Liu J, Wang Y, Zhang Q and Du X (2025) Association analysis-based screening strategy for quality markers of Tengdan capsule in the treatment of hypertensive renal disease. Front. Pharmacol. 16:1647921.

本文来自:    发布时间:2026-05-18

发表期刊:Frontiers in Pharmacology

发表时间:2025

Abstract:

Background and Aim: Hypertensive Renal Disease (HRD) is a chronic and progressive condition driven by sustained high blood pressure, which leads to renal fibrosis and, eventually, end-stage kidney failure. Tengdan Capsule (TDC), a traditional Chinese medicinal formulation, has shown therapeutic potential for managing HRD. However, the specific quality markers (Q-markers) responsible for its efficacy and the underlying molecular mechanisms remain insufficiently understood. This study aimed to identify candidate Q-markers of TDC and elucidate the molecular pathways through which it exerts its renoprotective effects, using an integrative association analysis-based approach.Methods: The chemical composition of TDC and its potential Q-markers were systematically characterized through in vitro and in vivo profiling using HPLC-Q-Exactive-MS and chromatographic fingerprinting. Transcriptomic analysis was conducted on angiotensin II-stimulated HEK293T cells to identify differentially expressed genes (DEGs) responsive to candidate Q-markers. Mendelian randomization (MR) analysis based on genome-wide association study (GWAS) data was employed to validate causal genes linked to HRD. Furthermore, untargeted metabolomics was performed to explore metabolic changes associated with transcriptomic targets.Results: A total of 82 chemical constituents were identified in TDC, 51 detected in vivo. Chromatographic fingerprinting across 10 production batches demonstrated high consistency. Integrated analysis of chemical profiling and fingerprint data highlighted Salvianolic acid B (Sal B) as a potential Q-marker. Transcriptomic profiling revealed 210 DEGs enriched in immune and fibrotic pathways. MR analysis identified Killer Cell Lectin Like Receptor D1 (KLRD1) as a protective gene associated with reduced HRD risk (IVW p = 0.00797), with no evidence of horizontal pleiotropy or heterogeneity. Metabolomic profiling identified five key metabolites, among which α,α′-diethyl-3,4,4′-stilbenetriol showed a strong correlation with KLRD1 expression, indicating a potential immune–metabolic regulatory axis.Conclusion: This study presents a novel framework for Q-marker identification in traditional herbal formulations using association-based multi-omics integration. Salvianolic acid B and KLRD1 were key indicators of TDC’s quality and efficacy. These findings offer new mechanistic insights into the action of TDC and support its standardized evaluation and therapeutic application in HRD management.

https://doi.org/10.3389/fphar.2025.1647921




上一篇:S.-Y.Xu, Y.Luo, X.-F.Liu, et al. “UPLC-MS/MS-Network Pharmacology an

下一篇:没有了

联系我们

4000-369-963  028-85370565

18080489829@163.com

四川省 成都市 武侯区 武科西二路8号

关于普思

 新闻资讯

研发机构

 服务平台

产品

中药化学对照品

化合物库

热销原料

技术服务

高分辨质谱分析

药物单体纯化

中药创新药

普思生物为您提供中药化学对照品、高纯化学试剂、天然产物化合物库等优质产品,
仅用于科学研究、工业应用等非医疗用途范畴,不可用于人的临床治疗或试验,非药用,非食用。

友情链接:全球化学品供应商搜索   盖德化工网    成都普思生物科技股份有限公司版权所有   蜀ICP备08100078号

在线
咨询

在线咨询服务时间:8:30-17:30

选择客服在线沟通:

咨询
热线

4000-369-963  
7*24小时客服服务热线


028-85370565 / 18080489829 (何女士)

关注
微信

关注官方微信
顶部